Dianthus Therapeutics (DNTH) Cash from Operations (2017 - 2025)
Dianthus Therapeutics' quarterly Cash from Operations came in at 30555000.0 in Q3 2025, down 43.67% year-on-year from 54246029.3 in Q3 2024, and down 27.89% quarter-over-quarter from 23892000.0 in Q2 2025.
Dianthus Therapeutics has reported Cash from Operations for 9 years, with the latest figure at 30555000.0 in Q3 2025.
- For the quarter ending Q3 2025, Cash from Operations fell 43.67% year-over-year to 30555000.0; the trailing twelve-month figure through Sep 2025 stood at 109521000.0 (down 74.98% YoY), and the FY2024 full-year result was 78180000.0, down 112.09% from the prior year.
- Cash from Operations for Q3 2025 stood at 30555000.0, down from 23892000.0 in the prior quarter.
- The five-year high for Cash from Operations was 16375000.0 in Q3 2022, with the low at 30555000.0 in Q3 2025.
- Average Cash from Operations over 5 years is 15037842.11, with a median of 14941000.0 recorded in 2024.
- Year-over-year, Cash from Operations jumped 216.41% in 2022 and sank 207.08% in 2024.
- Tracing DNTH's Cash from Operations over 5 years: stood at 15690000.0 in 2021, then soared by 43.59% to 8851000.0 in 2022, then slumped by 33.93% to 11854000.0 in 2023, then sank by 131.52% to 27444000.0 in 2024, then fell by 11.34% to 30555000.0 in 2025.
- The last three Cash from Operations figures came in at 30555000.0 (Q3 2025), 23892000.0 (Q2 2025), and 27630000.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 1.08 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 70.50 Mn |
| 10 | Dianthus Therapeutics | 4.02 Bn | 3.62 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -30.56 Mn |
| Sep 30, 2025 | -30.56 Mn |
| Jun 30, 2025 | -23.89 Mn |
| Jun 30, 2025 | -23.89 Mn |
| Mar 31, 2025 | -27.63 Mn |
| Mar 31, 2025 | -27.63 Mn |
| Dec 31, 2024 | -27.44 Mn |
| Dec 31, 2024 | -27.44 Mn |
| Sep 30, 2024 | -21.27 Mn |
| Sep 30, 2024 | -21.27 Mn |
| Jun 30, 2024 | -14.53 Mn |
| Jun 30, 2024 | -14.53 Mn |
| Mar 31, 2024 | -14.94 Mn |
| Mar 31, 2024 | -14.94 Mn |
| Dec 31, 2023 | -11.85 Mn |
| Dec 31, 2023 | -11.85 Mn |
| Sep 30, 2023 | -9.99 Mn |
| Sep 30, 2023 | -9.99 Mn |
| Jun 30, 2023 | -4.73 Mn |
| Jun 30, 2023 | -4.73 Mn |
| Mar 31, 2023 | -10.28 Mn |
| Mar 31, 2023 | -10.28 Mn |
| Dec 31, 2022 | -8.85 Mn |
| Dec 31, 2022 | -8.85 Mn |
| Sep 30, 2022 | 16.38 Mn |
| Sep 30, 2022 | 16.38 Mn |
| Jun 30, 2022 | -16.85 Mn |
| Jun 30, 2022 | -16.85 Mn |
| Mar 31, 2022 | -19.74 Mn |
| Mar 31, 2022 | -19.74 Mn |
| Dec 31, 2021 | -15.69 Mn |
| Dec 31, 2021 | -15.69 Mn |
| Sep 30, 2021 | -14.07 Mn |
| Sep 30, 2021 | -14.07 Mn |
| Jun 30, 2021 | -13.00 Mn |
| Jun 30, 2021 | -13.00 Mn |
| Mar 31, 2021 | -16.77 Mn |
| Mar 31, 2021 | -16.77 Mn |
| Dec 31, 2020 | -13.73 Mn |
| Dec 31, 2020 | -13.73 Mn |
| Sep 30, 2020 | -14.43 Mn |
| Sep 30, 2020 | -14.43 Mn |
| Jun 30, 2020 | -19.21 Mn |
| Jun 30, 2020 | -19.21 Mn |
| Mar 31, 2020 | -16.66 Mn |
| Mar 31, 2020 | -16.66 Mn |
| Dec 31, 2019 | -15.63 Mn |
| Dec 31, 2019 | -15.63 Mn |
| Sep 30, 2019 | -11.51 Mn |
| Sep 30, 2019 | -11.51 Mn |
| Jun 30, 2019 | -15.03 Mn |
| Jun 30, 2019 | -15.03 Mn |
| Mar 31, 2019 | -14.94 Mn |
| Mar 31, 2019 | -14.94 Mn |
| Dec 31, 2018 | -12.62 Mn |
| Dec 31, 2018 | -12.62 Mn |
| Sep 30, 2018 | -10.55 Mn |
| Sep 30, 2018 | -10.55 Mn |
| Jun 30, 2018 | -9.11 Mn |
| Jun 30, 2018 | -9.11 Mn |
| Mar 31, 2018 | -9.60 Mn |
| Mar 31, 2018 | -9.60 Mn |
| Dec 31, 2017 | -8.23 Mn |
| Dec 31, 2017 | -8.23 Mn |
| Sep 30, 2017 | -5.44 Mn |
| Sep 30, 2017 | -5.44 Mn |